Renin Angiotensin Aldosterone System (RAAS)


Renin-Angiotensin Aldosterone System

It is a hormone system involved in the regulation of blood pressure comprising of renin, aldosterone and angiotensin II 1.It is also a determinant of renal failure as it controls the balance of electrolytes in the body through coordinated on the kidneys, blood vessels as well as heart.


Renin Release

Renin is released from juxtaglomerular apparatus due to a number of factors;

  • Macula densa cells detect reduced delivery of sodium to the distal convoluted tubule.
  • Baroreceptors in the afferent arterioles detect reduced perfusion pressure.
  • Beta 1-adenoreceptors detects sympathetic stimulation of juxtaglomerular apparatus.


Production of Angiotensin II

Angiotensinogen is a protein cleaved by renin to angiotensin I which in turn gets converted to angiotensin II by angiotensin-converting enzyme (ACE), this takes place in liver 2.

  • Angiotensin II is a vasoconstrictor and binds to G-protein coupled receptors, AT1 and AT2.
  • Renal failure leads to an increase in the production of angiotensin II and thus vasoconstriction of renal vessels leads to hypertension 3 thus increasing workload on the heart and leads to heart failure 4.



Clinical Relevance

ACE inhibitors inhibit the action of angiotensin-converting enzyme thus reducing the levels of angiotensin II in the body consequently reducing the activity of RAAS. Therefore the physiological effects are;

  • Decreased cardiac output.
  • Decreased arteriolar vasoconstriction.
  • Reduced excretion of potassium from the kidneys.


By: ZOHA KHAN


References

  1. Atlas, S. A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J. Manag. care Pharm. 13, 9–20 (2007).
  2. Re, R. N. Mechanisms of disease: local renin–angiotensin–aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 1, 42–47 (2004).
  3. Onuigbo, M. A. C. & Onuigbo, N. T. C. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. QJM An Int. J. Med. 101, 519–527 (2008).
  4. Dzau, V. J. Tissue renin-angiotensin system: physiologic and pharmacologic implications. (American Heart Association, 1988).

Comments

Popular posts from this blog

Hydrogels

Innovations in Vaccinology: The Rise of Recombinant Genetic Shields

Registration Form for Volunteer Batch 2k22